Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single Center Investigator Sponsored Study Assessing the Effect of Tenapanor on Metagenomic and Metabolomic Markers in Patients With Irritable Bowel Syndrome With Constipation

NCT05995899 is registered in ClinicalTrials.gov with Kyle Staller, MD, MPH as lead sponsor.

NCT NCT05995899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05995899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single Center Investigator Sponsored Study Assessing the Effect of Tenapanor on Metagenomic and Metabolomic Markers in Patients With Irritable Bowel Syndrome With Constipation
Lead sponsor
Kyle Staller, MD, MPH
Phase
Phase 4
Overall status
Completed
Start date
February 6, 2024
Completion date
December 17, 2025
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs, ibs - irritable bowel syndrome